Supernus Pharmaceuticals - 12 Year Stock Price History | SUPN
Historical daily share price chart and data for Supernus Pharmaceuticals since 2012 adjusted for splits and dividends. The latest closing stock price for Supernus Pharmaceuticals as of November 19, 2024 is 35.53.
- The all-time high Supernus Pharmaceuticals stock closing price was 59.85 on June 29, 2018.
- The Supernus Pharmaceuticals 52-week high stock price is 39.37, which is 10.8% above the current share price.
- The Supernus Pharmaceuticals 52-week low stock price is 25.53, which is 28.1% below the current share price.
- The average Supernus Pharmaceuticals stock price for the last 52 weeks is 30.39.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Supernus Pharmaceuticals Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2024 |
30.6867 |
27.7300 |
37.8300 |
25.7700 |
35.5300 |
22.77% |
| 2023 |
32.5666 |
37.4700 |
42.0300 |
22.7200 |
28.9400 |
-18.87% |
| 2022 |
31.6678 |
30.0800 |
37.8800 |
25.3300 |
35.6700 |
22.33% |
| 2021 |
28.9560 |
25.1400 |
34.2200 |
23.5400 |
29.1600 |
15.90% |
| 2020 |
21.8370 |
23.7100 |
25.8100 |
14.4500 |
25.1600 |
6.07% |
| 2019 |
31.2652 |
32.7700 |
41.9900 |
19.9300 |
23.7200 |
-28.60% |
| 2018 |
46.5386 |
40.4500 |
59.8500 |
30.8400 |
33.2200 |
-16.64% |
| 2017 |
36.3333 |
25.9500 |
49.6500 |
23.4500 |
39.8500 |
57.82% |
| 2016 |
18.9972 |
13.1400 |
26.6800 |
10.1300 |
25.2500 |
87.87% |
| 2015 |
14.4964 |
8.2200 |
21.2600 |
8.1800 |
13.4400 |
61.93% |
| 2014 |
8.8842 |
7.6500 |
11.1300 |
7.3200 |
8.3000 |
10.08% |
| 2013 |
6.6794 |
7.2900 |
8.3800 |
4.5100 |
7.5400 |
5.16% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.962B |
$0.608B |
|
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
|
